Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00758953 · ClinicalTrials.gov registry record · Phase 2
Pain Associated With Endometriosis
A Phase 2 study, sponsored by Lumara Health.
- Completed
- Registry status
- Phase 2
- Development phase
- 66
- Enrollment target
NCT00758953: Completed Phase 2 study, sponsored by Lumara Health.
NCT00758953 is a Phase 2 study that has completed, run by Lumara Health. The registered enrollment target is 66 participants, below the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (50% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00758953, a Phase 2 study, has completed, sponsored by Lumara Health.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 66 participants
- Enrollment target
Study Summary
This study will evaluate the efficacy and safety of an investigational medication compared with placebo in the treatment of pain associated with endometriosis.
Interventions
- DRUG Danazol Once Weekly
- DRUG Danazol Twice Weekly
- DRUG Placebo Once Weekly
- DRUG Placebo Twice Weekly
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 66 participants |
| Start Date | 2007-02 |
| Est. Completion | 2009-01 |
| Phase | Phase 2 |
What the finished NCT00758953 record still lists
NCT00758953 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 66 participants, a relatively small participant target, below the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (50% lower).
The record links to 0 conditions, and to 4 interventions - of which Danazol Once Weekly is the first listed.
NCT00758953 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00758953 about?
NCT00758953 is a clinical study titled "Pain Associated With Endometriosis". This study will evaluate the efficacy and safety of an investigational medication compared with placebo in the treatment of pain associated with endometriosis.
What is the current status of trial NCT00758953?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 66 participants. The study started on 2007-02. Estimated completion is 2009-01.
What interventions are being tested in trial NCT00758953?
The interventions under investigation include: Danazol Once Weekly (DRUG), Danazol Twice Weekly (DRUG), Placebo Once Weekly (DRUG), Placebo Twice Weekly (DRUG).
Who is sponsoring clinical trial NCT00758953?
This trial is sponsored by Lumara Health, which has 6 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00758953's enrollment target sits among peer trials
66 975th of 2000 higher than 1,014 of 2,000 other Phase 2 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 2 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02584244 · 66 participants · Phase 1
Feasibility of the LUM Imaging System for Detection of Gastrointestinal Cancers
- NCT03067051 · 66 participants · Phase 1
Clinical Study to Assess the Safety and Efficacy of the SpectraCure P18 System
- NCT03754725 · 66 participants · Phase 1
Ferritin and Iron Burden in SAH sIRB
- NCT03875378 · 66 participants · Phase 2
Transdermal Estrogen in Women With Anorexia Nervosa
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia